Global Histone Deacetylase 1 Market Survey and Trend Research 2018

September 2018 | 85 pages | ID: G202953EC8BEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., HitGen LTD, HitGen LTD, IRBM Science Park SpA, Italfarmaco S.p.A., MEI Pharma, Inc., Merck & Co., Inc., Mirati Therapeutics Inc., Oncolys BioPharma Inc., Sigma-Tau S.p.A., Syndax Pharmaceuticals, Inc., TetraLogic Pharmaceuticals etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Histone Deacetylase 1 Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HISTONE DEACETYLASE 1 MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 4SC AG (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Acetylon Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Chipscreen Biosciences Ltd (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Curis, Inc. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 HitGen LTD (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 HitGen LTD (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 IRBM Science Park SpA (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Italfarmaco S.p.A. (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 MEI Pharma, Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Merck & Co., Inc. (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Mirati Therapeutics Inc. (Company Overview, Sales Data etc.)
4.12 Oncolys BioPharma Inc. (Company Overview, Sales Data etc.)
4.13 Sigma-Tau S.p.A. (Company Overview, Sales Data etc.)
4.14 Syndax Pharmaceuticals, Inc. (Company Overview, Sales Data etc.)
4.15 TetraLogic Pharmaceuticals (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Histone Deacetylase 1 Market 2012-2017, by Type, in USD Million
Table Global Histone Deacetylase 1 Market Forecast 2018-2023, by Type, in USD Million
Table 4SC AG Overview List
Table Histone Deacetylase 1 Business Operation of 4SC AG (Sales Revenue, Cost, Gross Margin)
Table Acetylon Pharmaceuticals, Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Acetylon Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table Chipscreen Biosciences Ltd Overview List
Table Histone Deacetylase 1 Business Operation of Chipscreen Biosciences Ltd (Sales Revenue, Cost, Gross Margin)
Table Curis, Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Curis, Inc. (Sales Revenue, Cost, Gross Margin)
Table HitGen LTD Overview List
Table Histone Deacetylase 1 Business Operation of HitGen LTD (Sales Revenue, Cost, Gross Margin)
Table HitGen LTD Overview List
Table Histone Deacetylase 1 Business Operation of HitGen LTD (Sales Revenue, Cost, Gross Margin)
Table IRBM Science Park SpA Overview List
Table Histone Deacetylase 1 Business Operation of IRBM Science Park SpA (Sales Revenue, Cost, Gross Margin)
Table Italfarmaco S.p.A. Overview List
Table Histone Deacetylase 1 Business Operation of Italfarmaco S.p.A. (Sales Revenue, Cost, Gross Margin)
Table MEI Pharma, Inc. Overview List
Table Histone Deacetylase 1 Business Operation of MEI Pharma, Inc. (Sales Revenue, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Merck & Co., Inc. (Sales Revenue, Cost, Gross Margin)
Table Mirati Therapeutics Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Mirati Therapeutics Inc. (Sales Revenue, Cost, Gross Margin)
Table Oncolys BioPharma Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Oncolys BioPharma Inc. (Sales Revenue, Cost, Gross Margin)
Table Sigma-Tau S.p.A. Overview List
Table Histone Deacetylase 1 Business Operation of Sigma-Tau S.p.A. (Sales Revenue, Cost, Gross Margin)
Table Syndax Pharmaceuticals, Inc. Overview List
Table Histone Deacetylase 1 Business Operation of Syndax Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)
Table TetraLogic Pharmaceuticals Overview List
Table Histone Deacetylase 1 Business Operation of TetraLogic Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Histone Deacetylase 1 Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Histone Deacetylase 1 Sales Revenue Share, by Companies, in USD Million
Table Histone Deacetylase 1 Demand 2012-2017, by Application, in USD Million
Table Histone Deacetylase 1 Demand Forecast 2018-2023, by Application, in USD Million
Table Global Histone Deacetylase 1 Market 2012-2017, by Region, in USD Million
Table Histone Deacetylase 1 Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Histone Deacetylase 1 Industry Chain Structure
Figure Global Histone Deacetylase 1 Market Growth 2012-2017, by Type, in USD Million
Figure Global Histone Deacetylase 1 Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region